Weight loss medications stories

Sep 8, 2026

GLP-1 drugs linked to reduced asthma and COPD attacks in new studies

New research shows that GLP-1 receptor agonists like semaglutide, commonly used for weight loss and diabetes treatment, are associated with fewer exacerbations in patients with asthma and chronic obstructive pulmonary disease (COPD). The findings are based on real-world patient data and add to growing evidence of respiratory benefits from these medications.

Sep 8, 20263 sources

Aug 10, 2026

UK becomes first European country to approve Eli Lilly's once-daily weight loss pill Foundayo

The UK's Medicines and Healthcare products Regulatory Agency has authorized orforglipron (brand name Foundayo), a once-daily oral medication from Eli Lilly for treating obesity and type 2 diabetes, making the UK the first country in Europe to approve the drug.

Aug 10, 20266 sources

Jul 30, 2026

Study examines potential link between GLP-1 drugs and temporary hair loss

New research suggests that GLP-1 medications like Ozempic and Wegovy may increase the risk of temporary hair loss, though the overall risk appears to be low.

Jul 30, 20261 source